Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Freshpet (FRPT) Liabilities and Shareholders Equity (2016 - 2026)

Freshpet's Liabilities and Shareholders Equity history spans 13 years, with the latest figure at $1.8 billion for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 12.88% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.7 billion, a 10.44% increase, with the full-year FY2025 number at $1.8 billion, up 12.88% from a year prior.
  • Liabilities and Shareholders Equity hit $1.8 billion in Q4 2025 for Freshpet, up from $1.7 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for FRPT hit a ceiling of $1.8 billion in Q4 2025 and a floor of $758.3 million in Q3 2021.
  • Historically, Liabilities and Shareholders Equity has averaged $1.3 billion across 5 years, with a median of $1.4 billion in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 90.22% in 2021 and later grew 5.3% in 2025.
  • Tracing FRPT's Liabilities and Shareholders Equity over 5 years: stood at $784.4 million in 2021, then soared by 43.47% to $1.1 billion in 2022, then soared by 30.13% to $1.5 billion in 2023, then grew by 7.54% to $1.6 billion in 2024, then increased by 12.88% to $1.8 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for FRPT at $1.8 billion in Q4 2025, $1.7 billion in Q3 2025, and $1.6 billion in Q2 2025.